PuriCore's endoscope disinfector
This article was originally published in Clinica
PuriCore has received US FDA 510(k) market clearance for its Sterilox endoscopy high-level disinfectant system for use in reprocessing and disinfecting heat-sensitive medical instruments between patient procedures. The technology produces principally hypochlorous acid - an antimicrobial - from the electrolysis of a saline solution. Sterilox solutions are non-toxic and of no risk to patients, healthcare professionals, or the environment, claimed the company. "This is a big step in bringing Sterilox to the US endoscopy market, which is the largest in the world," said Greg Bosch, CEO of the Malvern, Pennsylvania firm, which anticipates installing its first US beta sites for Sterilox by the end of this year.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.